Brief: Tetra Bio-Pharma Reports Positive Initial Data from Both Ongoing Trials of QIXLEEF

Tetra Bio Pharma

29/11/2021 12:34

Nov 29 (Reuters) - Tetra Bio Pharma Inc  TBP.TO :
    * TETRA BIO-PHARMA ANNOUNCES POSITIVE INITIAL CLINICAL DATA
FROM
BOTH OF ITS ONGOING PHASE 2 CLINICAL TRIALS OF QIXLEEF™
    * TETRA BIO PHARMA INC - SAFETY DATA OF REBORN 1 TRIAL
COLLECTED
UP TO NOW CONFIRM QIXLEEF TOLERABILITY AND GOOD SAFETY PROFILE
    * TETRA BIO PHARMA INC - PRELIMINARY ANALYSIS OF DATA SHOWS
A
POSITIVE EFFECT ON PAIN RELIEF IN QIXLEEF-TREATED PATIENTS
    * TETRA BIO PHARMA INC - CANNOT DISCLOSE FURTHER DATA ON
EFFICACY
DUE TO REGULATORY COMPLIANCE
    * TETRA BIO PHARMA INC -  PRELIMINARY DATA OF PLENITUDE
TRIAL ALSO
CONFIRM QIXLEEF  TOLERABILITY AND GOOD SAFETY PROFILE

Source text for Eikon:  ID:nPn8bVVLha 
Further company coverage:  TBP.TO 

 ((Reuters.Briefs@thomsonreuters.com;))